However, studies in gastric cancer, clear renal cell carcinoma, colorectal cancer, and non-small cell lung cancer have reported a direct correlation between increased EpCAM expression and an overall better prognosis of patients [35,36,37,38,39,40]. Here, EPCAM is linked to non-small cell lung carcinoma.